View Older Stories View More Recent Stories

Jan 28, 2025 06:44AM Rodman & Renshaw Starts Rein Therapeutics (RNTX) at Buy
Jan 28, 2025 06:44AM Rodman & Renshaw Starts PolyPid Ltd. (PYPD) at Buy
Jan 28, 2025 06:43AM Rodman & Renshaw Starts Talphera (TLPH) at Buy
Jan 28, 2025 06:31AM Rodman & Renshaw Starts INmune Bio Inc. (INMB) at Buy
Jan 27, 2025 06:58AM Compass Pathways (CMPS) PT Lowered to $9 at Rodman & Renshaw
Jan 21, 2025 08:32AM Kairos Pharma (KAPA) Provides Business Update and Outlook into 2025
Jan 21, 2025 08:30AM Kairos Pharma Provides Business Update and Outlook into 2025
Dec 20, 2024 06:42AM Rodman & Renshaw Starts Atara Biotherapeutics (ATRA) at Buy
Dec 19, 2024 05:48AM Rodman & Renshaw Starts TuHURA Biosciences (HURA) at Buy
Dec 18, 2024 01:02PM BioMedNewsBreaks — Kairos Pharma, Ltd. (NYSE: KAPA) Receives ‘Buy’ Recommendation, $12.00 Price Target in Rodman & Renshaw Research Report
Dec 11, 2024 04:08PM Rodman & Renshaw Starts FibroBiologics (FBLG) at Buy
Dec 6, 2024 09:57AM Rodman & Renshaw Starts Tharimmune, Inc. (THAR) at Buy
Nov 25, 2024 08:41AM Rodman & Renshaw Downgrades Cassava Sciences (SAVA) to Sell, PT $20 (from $107)
Nov 20, 2024 09:19AM Forte Biosciences (FBRX) Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 14, 2024 06:47AM Rodman & Renshaw Starts Rockwell Medical Technologies (RMTI) at Buy
Nov 14, 2024 06:43AM Rodman & Renshaw Starts Eupraxia Pharmaceuticals (EPRX) at Buy
Nov 14, 2024 06:42AM Rodman & Renshaw Starts Achieve Life Sciences (ACHV) at Buy
Nov 14, 2024 06:38AM Rodman & Renshaw Starts Adial Pharmaceuticals Inc (ADIL) at Buy
Nov 14, 2024 06:37AM Rodman & Renshaw Starts Omeros Corp. (OMER) at Buy
Nov 5, 2024 06:39AM Rodman and Renshaw Starts Bicara Therapeutics Inc (BCAX) at Buy
Oct 29, 2024 06:48AM Rodman & Renshaw Starts Quince Therapeutics Inc. (QNCX) at Buy
Oct 29, 2024 06:00AM Monopar Therapeutics (MNPR) Prices $19.2M Share Offering at $16.25/sh
Oct 28, 2024 04:00PM Monopar Therapeutics (MNPR) Announces Proposed Share Offering
Oct 23, 2024 06:44AM Rodman & Renshaw Downgrades Alto Neuroscience (ANRO) to Neutral
Oct 7, 2024 09:53AM Scilex Holding (SCLX) Signs $50M Registered Convertible Financing
Sep 27, 2024 09:10AM Biomea Fusion (BMEA) Gains 11%, Analysts Positive After FDA Lifts Clinical Holds on BMF-219 in Type 2 and Type 1 Diabetes Trials
Sep 13, 2024 03:45PM Syra Health (SYRA) Announces Closing of $2.1 Million Public Offering
Sep 12, 2024 06:11AM Syra Health (SYRA) Prices 3.2M Share Offering at $0.64/sh
Apr 24, 2024 08:00AM Scilex Holding (SCLX) Prices 15M Share Offering at $1/sh
Mar 5, 2024 09:30AM iSpecimen Inc. (ISPC) Enters $1.5M ATM
Feb 29, 2024 06:05PM Scilex Holding (SCLX) Prices 5.88M Share Offering at $1.70/sh
Jul 5, 2022 08:30AM DURECT Corp (DRRX) Appoints Timothy M. Papp as Chief Financial Officer
Mar 4, 2022 09:22AM Great Elm Capital Corp. Announces New Board Leadership
Mar 4, 2022 09:22AM Great Elm Capital Corp. Announces New Board Leadership
Sep 9, 2021 07:38AM New Hire Announcement- Managing Director of Investment Banking
Apr 5, 2021 06:27AM BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
Apr 5, 2021 06:27AM BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
Sep 10, 2020 08:00AM Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
Sep 10, 2019 11:29AM DirectView’s CEO Roger Ralston Attends The Rodman & Renshaw 21st Annual Global Investment Conference Hosted by H.C. Wainwright &Co.
Sep 6, 2019 05:29PM Oragenics Inc. to Present September 10 at the 21st Annual Rodman and Renshaw Global Investment Conference
Sep 6, 2019 05:19PM M2 Compliance to Sponsor Rodman & Renshaw 21st Annual Global Investment Conference
Sep 6, 2019 08:30AM Atossa Genetics to Present September 10 at the 21st Annual Rodman and Renshaw Global Investment Conference
Sep 6, 2019 07:30AM Agile Therapeutics to Present at Upcoming Investor Conferences
Sep 6, 2019 07:30AM Agile Therapeutics to Present at Upcoming Investor Conferences
Sep 6, 2019 06:30AM AIM ImmunoTech to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 10th
Sep 5, 2019 07:00AM CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference
Sep 4, 2019 09:00AM Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
Sep 4, 2019 08:00AM DURECT to Present at the 21st Annual Rodman and Renshaw Global Investment Conference Sponsored by H.C. Wainwright
Sep 3, 2019 05:58PM Ur-Energy to Present September 9 at the 21st Annual Rodman & Renshaw Global Investment Conference
View More Recent Stories View Older Stories